Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Medtronic
Argus Health
Accenture
Mallinckrodt
UBS
Daiichi Sankyo
QuintilesIMS
Fish and Richardson
AstraZeneca

Generated: January 19, 2018

DrugPatentWatch Database Preview

Terbutaline sulfate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for terbutaline sulfate and what is the scope of terbutaline sulfate patent protection?

Terbutaline sulfate
is the generic ingredient in four branded drugs marketed by Novartis, Sanofi Aventis Us, Pharmacare, Akorn, Athenex Inc, Fresenius Kabi Usa, Hikma Farmaceutica, Teva Pharms Usa, United Biomedcl, Ani Pharms Inc, Impax Labs, and Lannett, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for terbutaline sulfate. Thirteen suppliers are listed for this compound.
Medical Subject Heading (MeSH) Categories for terbutaline sulfate

US Patents and Regulatory Information for terbutaline sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us BRICANYL terbutaline sulfate TABLET;ORAL 017618-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us BRICANYL terbutaline sulfate INJECTABLE;INJECTION 017466-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us BRICANYL terbutaline sulfate AEROSOL, METERED;INHALATION 018000-001 Mar 19, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Athenex Inc TERBUTALINE SULFATE terbutaline sulfate INJECTABLE;INJECTION 076770-001 Apr 23, 2004 AP RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us BRICANYL terbutaline sulfate TABLET;ORAL 017618-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Akorn TERBUTALINE SULFATE terbutaline sulfate INJECTABLE;INJECTION 078151-001 Jan 7, 2008 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hikma Farmaceutica TERBUTALINE SULFATE terbutaline sulfate INJECTABLE;INJECTION 078630-001 May 20, 2009 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ani Pharms Inc BRETHINE terbutaline sulfate TABLET;ORAL 017849-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lannett TERBUTALINE SULFATE terbutaline sulfate TABLET;ORAL 077152-002 Mar 25, 2005 RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
United Biomedcl TERBUTALINE SULFATE terbutaline sulfate INJECTABLE;INJECTION 200122-001 Nov 8, 2013 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for terbutaline sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacare BRETHINE terbutaline sulfate INJECTABLE;INJECTION 018571-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Ani Pharms Inc BRETHINE terbutaline sulfate TABLET;ORAL 017849-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Novartis BRETHAIRE terbutaline sulfate AEROSOL, METERED;INHALATION 018762-001 Aug 17, 1984 ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us BRICANYL terbutaline sulfate INJECTABLE;INJECTION 017466-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us BRICANYL terbutaline sulfate TABLET;ORAL 017618-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us BRICANYL terbutaline sulfate TABLET;ORAL 017618-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Ani Pharms Inc BRETHINE terbutaline sulfate TABLET;ORAL 017849-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us BRICANYL terbutaline sulfate TABLET;ORAL 017618-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us BRICANYL terbutaline sulfate TABLET;ORAL 017618-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Novartis BRETHAIRE terbutaline sulfate AEROSOL, METERED;INHALATION 018762-001 Aug 17, 1984 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
McKesson
Merck
Covington
Argus Health
Cipla
Farmers Insurance
Johnson and Johnson
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot